GlassScriptPhysician profile
William J Tingle
NPI 1083701452
$4,375.79
in general payments reported to CMS, 2019-2025
41 companies · $33.83 in 2025
The $33.83 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $198 · 2021: $69.32 · 2022: $685 · 2023: $1,070 · 2024: $1,146 · 2025: $33.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $584.01 | 2019-2024 | Xiaflex, Edex, Aveed |
| Coloplast Corp | $398.72 | 2019-2024 | Titan, Speedicath, Porges Coloplast |
| Janssen Biotech, INC. | $326.23 | 2019-2024 | Erleada |
| Axonics, INC. | $302.64 | 2023-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $279.19 | 2019-2024 | Xtandi, Myrbetriq, Veozah |
| Boston Scientific Corporation | $236.42 | 2019-2024 | Spaceoar Vue System - 10ml, Rezum Generator, Spectra |
| Procept Biorobotics Corporation | $211.51 | 2024 | Aquabeam System |
| Abbvie INC. | $197.44 | 2022-2024 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $171.31 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $152.03 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $127.54 | 2019-2022 | |
| Rochester Medical Corporation | $107.81 | 2019-2020 | |
| Endo USA, INC. | $98.16 | 2024 | Aveed, Xiaflex, Edex |
| Teleflex LLC | $92.84 | 2023-2024 | Urolift |
| Urogen Pharma, INC. | $82.63 | 2022-2024 | Jelmyto |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tingle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.